• Mayelana Us - CHG
  • Iziguli Zomhlaba Wonke
  • Khokha ku-inthanethi
  • Careers
  • Buza Manje
  • Impendulo
  • Isithombe Sendawo
isithonjana
×

I-Saroglitazar

I-Saroglitazar iyi-peroxisome proliferator-activated receptor inhibitor (PPAR) inhibitor esetshenziselwa ukuphatha nokulawula i-cholesterol ephezulu kubantu sikashukela (isifo sikashukela i-dyslipidemia). Iyasiza ekulawuleni i-cholesterol ephezulu, ikakhulukazi i-triglycerides, kanye namazinga aphezulu eglucose egazini kubantu abanayo thayipha 2 sikashukela. I-Saroglitazar iyisensitiser se-insulin kanye nomuthi wesigaba sokuqala osebenza njenge-agonist ekabili ye-PPAR kuma-subtypes α (alpha) no-γ (gamma) we-PPAR.

shayela nathi
bhuka i-aphoyintimenti

Ukusetshenziswa kweSaroglitazar

Umsebenzi oyinhloko we-saroglitazar ukulawula i-dyslipidemia (amazinga aphezulu e-lipid egazini) ezigulini ezinesifo sikashukela sohlobo 2. Indlela yayo embaxambili yokusebenza iqondise kukho kokubili ukuphazamiseka kwe-lipid ne-glucose, okuyenza ibe yindlela yokwelapha ebalulekile. Ukusetshenziswa okubalulekile kwe-saroglitazar kuhlanganisa:

  • I-Diabetic Dyslipidemia: Odokotela ngokuvamile batusa i-saroglitazar ekwelapheni isifo sikashukela i-dyslipidemia, isimo esibonakala ngamazinga aphakeme e-triglyceride, i-cholesterol ephansi ye-HDL (enhle) kanye ne-cholesterol ephezulu ye-LDL (embi) kulabo abanesifo sikashukela sohlobo 2.
  • I-Hypertriglyceridemia: I-Saroglitazar iyasebenza ekwehliseni amazinga e-triglyceride aphakeme, ukungahambi kahle kwe-lipid okuvamile okuhambisana nengozi eyandayo yezifo zenhliziyo nemithambo yegazi.
  • Ukuthuthukisa Ukulawula I-Glycemic: Ngokungeziwe emiphumeleni yayo yokwehlisa i-lipid, i-saroglitazar isiza futhi ukuthuthukisa ukulawulwa kwe-glycemic ngokunciphisa amazinga e-HbA1c (isilinganiso sokulawula ushukela wegazi isikhathi eside).
  • I-Non-Alcoholic Fatty Liver Disease (NAFLD): I-Saroglitazar ibonise imiphumela ethembisayo ekuphathweni kwe-NAFLD, isimo esibonakala ngokuhlangana kwamafutha kumaseli esibindi. Ingaqhubekela ezimeni ezinzima kakhulu njenge-non-alcoholic steatohepatitis (NASH).
  • Ukusetshenziswa Okungenzeka Ku-Metabolic Syndrome: Ngenxa yesenzo sayo esimbaxambili ku-lipid ne-glucose metabolism, i-saroglitazar ingasiza futhi ekulawuleni i-metabolic syndrome, iqoqo lezifo ezandisa ubungozi besifo senhliziyo nemithambo yegazi kanye nohlobo 2 sikashukela.

Ungayisebenzisa kanjani iSaroglitazar

Odokotela abaningi batusa umthamo we-4 mg ngosuku, othathwe ngomlomo ngaphambi kokudla kokuqala kosuku. I-Saroglitazar itholakala njengamaphilisi angamboziwe, ngalinye liqukethe i-4 mg noma 2 mg yesithako esisebenzayo.

Administration

  • Thatha i-saroglitazar njengoba nje ushilo udokotela wakho.
  • Thatha yonke ithebhulethi ngengilazi yamanzi. Gwema ukuchoboza, ukuhlafuna, noma ukuphula ithebhulethi.
  • Kunconywa ukuthatha i-saroglitazar ngaphambi kokudla kokuqala kosuku.

Imiphumela Emibi Yethebhulethi yeSaroglitazar

I-Saroglitazar ivame ukubekezelelwa kahle; iziguli eziningi azibi nazo imiphumela emibi kakhulu uma zithathwa ngesilinganiso esinconywayo. Nokho, okulandelayo yimiphumela engemihle evamile:

Ngokuvamile, i-saroglitazar ayibangeli i-hypoglycemia (amazinga aphansi kashukela egazini). Kodwa-ke, kwezinye iziguli, iziqephu ze-hypoglycemic zingenzeka, okudinga ukulungiswa komthamo we-insulin wansuku zonke ngaphansi kokuholwa ngudokotela. 

Ukuqapha

Lapho uthatha i-saroglitazar, kubalulekile ukucabangela lezi zinyathelo zokuphepha ezilandelayo:

  • I-Saroglitazar kufanele isetshenziswe ngokuqapha ezigulini ezinesibindi kanye nesibindi isifo sezinso. 
  • Iziguli ezinomlando wesifo senhliziyo kufanele zisebenzise i-saroglitazar ngokuqapha. 
  • Ngenkathi i-saroglitazar ithinta ngokuyinhloko amazinga e-lipid, ingaba nomthelela namazinga eglucose egazini. Gada amazinga kashukela egazini njalo, ikakhulukazi uma uphuzwa neminye imithi ye-antidiabetic.

Isebenza kanjani iSaroglitazar

Kuyi-agonist ye-peroxisome proliferator-activated receptor (PPAR) agonist, okusho ukuthi yenza kokubili i-PPAR-α kanye ne-PPAR-γ receptors. Le ndlela yokusebenza ekabili ivumela i-saroglitazar ukuthi yenze imiphumela yayo yokwelapha ku-lipid kanye ne-glucose. i-metabolism:

Ngingakwazi ukuthatha i-Saroglitazar Neminye Imithi?

I-Saroglitazar ingakwazi ukusebenzisana nemithi ethile, futhi kubalulekile ukubonana nodokotela ngaphambi kokuyithatha ngokuhlangana nezinye izidakamizwa. Nazi ezinye izinto ezibalulekile mayelana nokusetshenziswa kanyekanye kwe-saroglitazar neminye imithi:

  • Imithi Ye-Antidiabetic: Lapho i-saroglitazar ithathwa kanye neminye imishanguzo ye-antidiabetic, njenge-metformin, i-sulfonylureas, noma i-insulin, ayanda amathuba okuba ne-hypoglycemia (amazinga aphansi kashukela egazini). Iziguli kufanele ziqaphe ngokucophelela amazinga azo kashukela egazini futhi zilungise umthamo wemithi yazo ye-antidiabetic njengoba kuncoma udokotela wazo.
  • Imithi Yokwehlisa I-Cholesterol: I-Saroglitazar ingathuthukisa imiphumela yemithi yokwehlisa i-cholesterol, njengama-statins noma ama-fibrate. Le nhlanganisela ingandisa ingozi yemiphumela emibi ehlobene nemisipha, okuhlanganisa i-myopathy (ubuthakathaka bemisipha) kanye ne-rhabdomyolysis (ukuwohloka kwemicu yemisipha). 
  • I-Blood Thinners: I-Saroglitazar ingase ihlanganyele nama-blood thinners, njenge-warfarin, okwandisa ingozi yokopha. Lapho uthatha i-saroglitazar ene-blood thinners, kunconywa ukubhekwa njalo kwemingcele yokuvala igazi, njenge-international normalized ratio (INR).
  • Imithi I-Metabolised yi-CYP Enzymes: I-Saroglitazar yenziwa i-cytochrome P450 (CYP) enzyme system, ikakhulukazi i-CYP2C8 ne-CYP3A4. Imithi evimbela noma enxenxa lawa ma-enzyme ingashintsha imetabolism namazinga egazi e-saroglitazar, okungase kwandise noma kwehlise imiphumela yayo yokwelapha.

Ulwazi lomthamo

Odokotela ngokuvamile batusa 4 mg ngosuku, ethathwa ngomlomo ngaphambi kokudla kosuku lokuqala. I-Saroglitazar itholakala njengamaphilisi angamboziwe, ngalinye liqukethe i-4 mg noma i-2 mg yesithako esisebenzayo. Kubalulekile ukuthatha i-saroglitazar njengoba udokotela wakho eluleka futhi ulandele uhlobo lwemithamo enqunyiwe. 

Imibuzo Evame Ukubuzwa

1. Ingabe i-Saroglitazar iphephile?

I-Saroglitazar ngokuvamile ibhekwa njengephephile futhi ibekezelelwa kahle iziguli. Eminye imiphumela emibi emincane ubuthakathaka, imfiva, ukuvuvukala kwesisu, isicanucanu, ukuhlanza, ubuhlungu besifuba, isiyezi, isifo sofuba, i-asthenia (ukuntula amandla noma amandla), kanye ne-pyrexia (imfiva). Nokho, le miphumela engemihle ngokuvamile imnene futhi iyalawuleka.

2. Ingabe i-saroglitazar ilungele isibindi esinamafutha?

Yebo, i-saroglitazar ibonise imiphumela ethembisayo ekuphathweni kwe-non-alcoholic fatty liver disease (NAFLD) & non-alcoholic steatohepatitis (NASH). Ucwaningo luye lwabonisa ukuthi i-saroglitazar ingathuthukisa ama-enzyme esibindi, yehlise okuqukethwe kwamafutha esibindi, futhi yehlise ukuqina kwesibindi ezigulini ezine-NAFLD ne-NASH. 

3. Ungathatha isikhathi esingakanani i-saroglitazar?

Udokotela wakho ngokuvamile unquma ubude besikhathi sokwelashwa kwakho nge-saroglitazar ngokusekelwe esimweni sakho kanye nempendulo yemithi. 

4. Ingabe umuthi i-saroglitazar uzilungele izinso?

I-Saroglitazar ngokuvamile ayihlotshaniswa nemiphumela emibi ekusebenzeni kwezinso noma ukulimala kwezinso. Kodwa-ke, njengesinyathelo sokuqapha, odokotela bahlala beqaphile ngenkathi beqala ukwelashwa kwe-saroglitazar ezigulini ezinomsebenzi wezinso ongajwayelekile.

5. Ingabe i-Saroglitazar ingadala i-hypoglycemia?

I-Saroglitazar ngokwayo ayibangeli i-hypoglycemia (amazinga aphansi kashukela egazini). Kodwa-ke, kwezinye iziguli ezithatha i-sulfonylurea noma insulin ekulawulweni kwesifo sikashukela, iziqephu ze-hypoglycemic zingenzeka. Ezimweni ezinjalo, umthamo wansuku zonke we-insulin ungadinga ukulungiswa ngaphansi kokuholwa ngudokotela. 

6. Ingabe i-Saroglitazar ibangela ukuncipha kwesisindo?

I-Saroglitazar isetshenziswa ngokuyinhloko ukuphatha i-dyslipidemia yesifo sikashukela kanye ne-hypertriglyceridemia ezigulini ezinesifo sikashukela sohlobo 2. Nakuba ngokuyinhloko ihlose amazinga e-lipid ne-glucose, ezinye iziguli zingase zithole ukulahlekelwa isisindo njengomphumela wesibili. Nokho, ukuncipha kwesisindo akuwona umsebenzi wawo oyinhloko.

7. Kufanele ithathwe nini amaphilisi eSaroglitazar?

Odokotela ngokuvamile batusa ukuthatha ithebhulethi i-saroglitazar ngaphambi kokudla kokuqala kosuku. Kodwa-ke, kubalulekile ukuthobela izinkombandlela zikadokotela wakho futhi uthathe i-saroglitazar njengoba uyalelwe ngaphandle kokulungisa umthamo noma ukuyeka umuthi ngaphandle kokuthintana nabo kuqala.